Effect of the BTL-899 Therapy for Non-invasive Lipolysis and Circumference Reduction of Abdomen

Improvement of Abdomen Appearance Clinical Trial

Official title: Evaluation of Safety and Efficacy of the BTL-899 Device for Non-invasive Lipolysis and Circumference Reduction of Abdomen

Status Completed

Clinical Trial Summary

The study is a prospective open-label single-arm study that includes three treatment procedures and four follow-up visits.

Clinical Trial Description

This study will evaluate the clinical efficacy and safety of the BTL-899 device for non-invasive lipolysis and circumference reduction of abdomen. The study is a prospective open-label single-arm study. The subjects will be enrolled and assigned into a single study group. Subjects will complete three (3) treatment visits and will be invited to four (4) follow-up visits 1, 2, 3 and 6-months after the final treatment. 6-months follow-up visit is the optional one. ;

Related Conditions & MeSH terms

• Improvement of Abdomen Appearance

• NCT number: NCT03270150
• Study type: Interventional
• Source: BTL Industries Ltd.
• Status: Completed
• Phase: N/A
• Start date: September 1, 2017
• Completion date: October 3, 2018